These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 10939572

  • 1. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J.
    Ann Neurol; 2000 Aug; 48(2):211-9. PubMed ID: 10939572
    [Abstract] [Full Text] [Related]

  • 2. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

  • 3. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.
    J Neurol Sci; 2010 Nov 15; 298(1-2):96-100. PubMed ID: 20810130
    [Abstract] [Full Text] [Related]

  • 4. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May 15; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 5. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I, Génin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D, Clerget-Darpoux F, Yaouanq J, Edan G, Rosenheim M, Fontaine B.
    Genes Immun; 2008 Sep 15; 9(6):570-4. PubMed ID: 18615093
    [Abstract] [Full Text] [Related]

  • 6. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Sep 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 7. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W, Wu JS, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    J Clin Neurosci; 2010 Aug 15; 17(8):1009-13. PubMed ID: 20580995
    [Abstract] [Full Text] [Related]

  • 8. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD.
    J Hum Genet; 2009 Sep 15; 54(9):547-9. PubMed ID: 19629136
    [Abstract] [Full Text] [Related]

  • 9. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 11. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O, Fernández V, Alonso A, Caballero A, Luque G, Bravo M, León A, Mayorga C, Leyva L, de Ramón E.
    J Neurol; 2004 Apr 15; 251(4):440-4. PubMed ID: 15083289
    [Abstract] [Full Text] [Related]

  • 12. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM, Zhang KN, Wang CD, Xiong YQ, Liu Z, Qu XH, Xie XF.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2741-4. PubMed ID: 18167262
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC.
    Neurology; 2009 Dec 15; 73(24):2107-11. PubMed ID: 20018638
    [Abstract] [Full Text] [Related]

  • 15. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF.
    Eur J Neurol; 2007 Aug 15; 14(8):835-40. PubMed ID: 17662002
    [Abstract] [Full Text] [Related]

  • 16. Pars planitis: clinical features and class II HLA associations.
    Raja SC, Jabs DA, Dunn JP, Fekrat S, Machan CH, Marsh MJ, Bressler NM.
    Ophthalmology; 1999 Mar 15; 106(3):594-9. PubMed ID: 10080220
    [Abstract] [Full Text] [Related]

  • 17. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C, Guerini FR, Rombolà G, Rosati E, Massacesi L, Ferrante P, Caputo D, Talamanca LF, Naldi P, Liguori M, Alizadeh M, Momigliano-Richiardi P, D'Alfonso S.
    J Neuroimmunol; 2004 May 15; 150(1-2):178-85. PubMed ID: 15081263
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL, Rodriguez-Rodero S, Tunon A, Martinez-Borra J, Vidal-Castineira JR, Lopez-Vazquez A, Rodrigo L, Rodrigo P, González S, Lahoz CH, Lopez-Larrea C.
    Tissue Antigens; 2008 Jul 15; 72(1):54-9. PubMed ID: 18588574
    [Abstract] [Full Text] [Related]

  • 20. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.
    Hum Mol Genet; 2009 Jan 15; 18(2):261-6. PubMed ID: 19098025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.